Behavioral Health Drug Updates
This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including new drugs for treating attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and more. What do behavioral health care providers need to know about these new medications?
Genoa Healthcare’s Vice President of Pharmacy Solutions Abbie Vogler, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:
- Explores new behavioral health drugs approved in 2021
- Reviews 2020 drug approvals and the recent pace of FDA approvals
- Looks ahead to coming drug trends
- Provides an update on COVID-19 vaccine developments
You can also read highlights from this webinar here and check out our FAQ here.
To learn more about how Genoa can help you and those you serve, contact us today.
